Oct 2026· European Heart Journal· Vol 47· 0 citations
TL;DR
It is demonstrated that OTULIN acts as a pathological driver of AAD by destabilizing DDX17 and activating the FGF2 axis and targeting OTULIN may represent a novel therapeutic strategy for AAD.
Abstract
Aortic aneurysm/dissection (AAD) is a life-threatening disease lacking effective pharmacological treatment. Protein ubiquitination plays a pivotal role in cardiovascular diseases. However, the possible contribution of the deubiquitinating enzyme OTULIN (OTU deubiquitinase with linear linkage specificity) to AAD pathogenesis remains elusive.
Through integrative analysis of RNA-sequencing data from human and mouse AAD tissues with a deubiquitinase database, we identified OTULIN as a key candidate. We generated vascular smooth muscle cell (VSMC)-specific OTULIN knockout mice and established an AAD model using β-aminopropionitrile (BAPN). We employed multiple molecular biological techniques to explore the role of OTULIN in VSMC phenotype switching.
We found that OTULIN was significantly increased in AAD patients and BAPN-induced AAD mice. VSMC-specific OTULIN knockout ameliorated BAPN-induced AAD, whereas VSMC-specific overexpression by rAAV9-SM22α-OTULIN (recombinant adeno-associated virus serotype 9 expressing Flag-tagged OTULIN under SM22α promoter) aggravated BAPN-induced AAD progression. Mechanistically, we identified DDX17 (DEAD-box helicase 17) as a substrate of OTULIN through interactome analysis. OTULIN removed the linear ubiquitin of DDX17 and promoted its proteasomal degradation. Consequently, Angiotensin II-induced DDX17 downregulation activated FGF2 transcription, leading to VSMC phenotype switching.
Our findings demonstrate that OTULIN acts as a pathological driver of AAD by destabilizing DDX17 and activating the FGF2 axis. Targeting OTULIN may represent a novel therapeutic strategy for AAD.
Aortic aneurysm/dissection (AAD) represents a life-threatening cardiovascular disorder characterized by vascular smooth muscle cells (VSMCs) phenotype switching from contractile to synthetic type and inflammatory responses. Current clinical management of AAD primarily relies on surgical intervention with little e...
D. Yang, J. Liu, Da-Dao-Yi Zhao et al.· European Heart Journal· 0 citations
Background Coronary artery aneurysm is a major cardiovascular complication of Kawasaki disease (KD). The phenotype switch of vascular smooth muscle cells (VSMCs) plays a crucial role in pathological vascular wall remodeling in KD; however, the molecular mechanisms driving this process remain incompletely understood. Al...
Xiao Xu, Yu-Cong Wei, Min Wang et al.· Frontiers in Immunology· 0 citations
Thoracic aortic dissection (TAD) is a lethal condition due to the risk of aortic rupture and malperfusion of arterial branches. Currently, effective treatments are unavailable due to the unclear pathogenic mechanisms; therefore, it is essential to explore the underlying mechanisms of TAD to find novel therapeutic targe...
Jian-Mao Hong, Bi-Jun Xu, Shi-Qiang Wang et al.· International Journal of Mol...· 0 citations
Background:
Thoracic aortic dissection (TAD) is a life-threatening vascular disease marked by medial degeneration, vascular smooth muscle cell (VSMC) loss, and extracellular matrix disruption, yet its underlying mechanisms remain poorly understood. Cyclin Y (CCNY), a cyclin family member involved in cellular homeost...
Kevin Chai· Circulation· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.